No abstract available
MeSH terms
-
Aged, 80 and over
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Disease Management
-
Disease Susceptibility
-
Female
-
Humans
-
Male
-
Myelodysplastic Syndromes / diagnosis*
-
Myelodysplastic Syndromes / drug therapy
-
Myelodysplastic Syndromes / etiology
-
Myelodysplastic Syndromes / mortality
-
Prognosis
-
Treatment Outcome